validated tissue glucose sensors dexcom g6 sensor Search Results


continuous glucose monitor cgm  (Dexcom Inc)
86
Dexcom Inc continuous glucose monitor cgm
Continuous Glucose Monitor Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitor cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
continuous glucose monitor cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
dexcom g6 pro sensor  (Dexcom Inc)
86
Dexcom Inc dexcom g6 pro sensor
Dexcom G6 Pro Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dexcom g6 pro sensor/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
dexcom g6 pro sensor - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
cardiac surgery surgical icu dexcom g6 pro laboratory poc mard  (Dexcom Inc)
86
Dexcom Inc cardiac surgery surgical icu dexcom g6 pro laboratory poc mard
Cardiac Surgery Surgical Icu Dexcom G6 Pro Laboratory Poc Mard, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cardiac surgery surgical icu dexcom g6 pro laboratory poc mard/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
cardiac surgery surgical icu dexcom g6 pro laboratory poc mard - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
cgm system  (Dexcom Inc)
86
Dexcom Inc cgm system
Cgm System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgm system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
cgm system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
dexcom g6 cgm system  (Dexcom Inc)
86
Dexcom Inc dexcom g6 cgm system
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Dexcom G6 Cgm System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dexcom g6 cgm system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
dexcom g6 cgm system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
cgm dexcom g6 cgm nr everyday  (Dexcom Inc)
86
Dexcom Inc cgm dexcom g6 cgm nr everyday
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Cgm Dexcom G6 Cgm Nr Everyday, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgm dexcom g6 cgm nr everyday/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
cgm dexcom g6 cgm nr everyday - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
islets tx dexcom g6  (Dexcom Inc)
86
Dexcom Inc islets tx dexcom g6
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Islets Tx Dexcom G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/islets tx dexcom g6/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
islets tx dexcom g6 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
dexcom g6 rt cgm  (Dexcom Inc)
86
Dexcom Inc dexcom g6 rt cgm
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Dexcom G6 Rt Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dexcom g6 rt cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
dexcom g6 rt cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
real time cgm  (Dexcom Inc)
86
Dexcom Inc real time cgm
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Real Time Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/real time cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
real time cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g6 subcutaneous continuous glucose monitoring  (Dexcom Inc)
86
Dexcom Inc g6 subcutaneous continuous glucose monitoring
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G6 Subcutaneous Continuous Glucose Monitoring, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6 subcutaneous continuous glucose monitoring/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g6 subcutaneous continuous glucose monitoring - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g6 continuous glucose monitoring cgm  (Dexcom Inc)
86
Dexcom Inc g6 continuous glucose monitoring cgm
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G6 Continuous Glucose Monitoring Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6 continuous glucose monitoring cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g6 continuous glucose monitoring cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
cgms  (Dexcom Inc)
86
Dexcom Inc cgms
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Cgms, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgms/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
cgms - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom G6 ® to Dexcom G7 ® (Day 0). Retrospective data collection: CGM data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.

Journal: Therapeutic Advances in Endocrinology and Metabolism

Article Title: Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology

doi: 10.1177/20420188251407515

Figure Lengend Snippet: Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom G6 ® to Dexcom G7 ® (Day 0). Retrospective data collection: CGM data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.

Article Snippet: The study recruited individuals with T1D from diabetes care centers who met the following inclusion criteria: (i) Diagnosis of T1D; (ii) Age ⩾18 years; (iii) Current use of the Tandem t:Slim X2 insulin pump with Control-IQ; (iv) Prior use of the Dexcom G6 CGM system for at least 3 months before study enrollment; (v) Willingness to transition to the Dexcom G7 system; (vi) Ability to provide informed consent and comply with study procedures; (vii) Adequate use of the system and adherence to the Control-IQ automatic mode.

Techniques: